Necrotizing Fasciitis Treatment Market

Necrotizing Fasciitis Treatment Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • October 2020
  • REP-GB-8415
  • Format: PDF/PPT/Excel
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Necrotizing Fasciitis Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Necrotizing Fasciitis Treatment market.

Necrotizing Fasciitis Treatment: Market Insights

Necrotizing Fasciitis is rare but serious bacterial infection commonly known as flesh eating disease which affects the tissue beneath the skin and surrounding organs and muscles. Necrotizing fasciitis start from the minor injury and get worse quickly. According to CDC, 500 to 1,000 cases of NF are diagnosed each year in the United States. The prognosis of necrotizing fasciitis becomes poor in the presence of co-morbidities such as immunosuppression, chronic alcohol disease, chronic renal failure, liver cirrhosis and diabetes mellitus. Early diagnosis of necrotizing fasciitis is imperative as any delay can be fatal, associated with more extensive surgery, high rate of amputation and high mortality rates. If necrotizing left untreated the infection can lead to systemic inflammatory response syndrome. Mortality rate of necrotizing fasciitis is still high despite the improved diagnostic tools and management of treatment in the past few years. Necrotizing fasciitis treatment include surgery to remove infected tissues, antibiotics and supportive treatment to control blood pressure, organ function and fluid levels. Necrotizing fasciitis progress very quick and lead to serious disease such as sepsis and organ failure.

  • Identify Key Market Forces and their Long-Term Forecast
  • Sneak Peek into Key Forecast Factors and thier Impact

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Necrotizing Fasciitis Treatment: Market Dynamics

Increasing prevalence of chronic disease and increasing focus on research and development of rare disease and development of new technology drive the market for necrotizing fasciitis treatment in the near future. Rising awareness and innovation in the therapy for wound and trauma along with the innovation in the diagnosis for rare disease drive the market of necrotizing fasciitis treatment in the forecast period. Use of non-steroidal anti-inflammatory drugs (NSAIDs) and steroid drugs which suppress fever, result in difficulty for diagnosis of disease and lack of specific treatment and diagnostic criteria hamper the growth of necrotizing fasciitis treatment market.

Necrotizing Fasciitis Treatment: Overview

Advancement in the technology driven treatment for rare disease significantly spur the market of Necrotizing Fasciitis Treatment. Recent development in the drug development and growing number of drug in the clinical trial, focus on technological and biological advances drive the market of Necrotizing Fasciitis Treatment in the near future. New technology and treatment with intravenous antibiotics option and development of new therapy will drive the market of intently modulated radiation therapy. Increasing prevalence of chronic disease and increase level of awareness for the rare disease also drive the market in the forecast period. On the basis of type, type I accounts for the largest revenue share owing to increased number of cases for type I in the necrotizing fasciitis. On the basis of end user, hospital pharmacies accounts for the largest revenue share owing to increasing number of hospital pharmacies in the forecast period

Necrotizing Fasciitis Treatment: Region-wise Outlook

The North America market for Necrotizing Fasciitis Treatment Market holds the largest revenue share, due to rising awareness on the diagnosis as well treatment of rare disease. Increasing disease related to bacterial infection and increasing research and development for new drug and treatment drive the market of North America. Europe accounts for the second large revenue share in the global necrotizing fasciitis treatment market, owing to increasing prevalence of chronic disease such as cancer, diabetes and infections. Asia Pacific is expected to witness rapid growth in the necrotizing fasciitis treatment market, due to government funding for rare disease and clinical trials and high prevalence of chronic diseases and developing healthcare infrastructure in countries such as India.  China is expected to register significant growth, owing to rising awareness about the bacterial infection and development of new treatment options. Latin America and Middle East & Africa are projected to exhibit slow growth in Necrotizing Fasciitis Treatment Market, owing to lack of awareness and limited treatment facilities and less developed healthcare infrastructure.

Necrotizing Fasciitis Treatment: Key Players

Examples of some of the key players present in the global necrotizing fasciitis treatment market are GlaxoSmithKline plc, Pfizer Inc, Bristol-Myers Squibb Company, Merck & Co., Inc, Abbott, Teva Pharmaceutical Industries Ltd among others.

The report covers exhaustive analysis on,

  • Necrotizing Fasciitis Treatment Market Segments
  • Necrotizing Fasciitis Treatment Market Dynamics
  • Historical Actual Market Size, 2012 – 2016
  • Necrotizing Fasciitis Treatment Market Size & Forecast 2016 to 2024
  • Necrotizing Fasciitis Treatment Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Necrotizing Fasciitis Treatment Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding China
  • China
  • Middle East & Africa

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Necrotizing Fasciitis Treatment Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Necrotizing Fasciitis Treatment: Segmentation

The global Necrotizing Fasciitis Treatment Market is segmented on basis of type, drug type and geography.

Segmentation by Type

  • Type I
  • Type II
  • Type III
  • Type IV

Segmentation by drug Type

  • Penicillin G
  • Carbapenems;
  • Metronidazole
  • Aminoglycoside
  • Clindamycin
  • Fluoroconazoles
  • Others

Segmentation by Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Necrotizing Fasciitis Treatment Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Necrotizing Fasciitis Treatment Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients


Request Sample Request customization Request Methodology